173
Participants
Start Date
June 25, 2018
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2027
Radotinib HCl
"1. Brand name/manufacturer: Supect Cap./IL-YANG PHARM. Co., Ltd.~2. Active ingredient: radotinib HCl 106.8mg (100mg as radotinib) or HCl 213.6mg (200mg as radotinib)~3. Appearance and formulation: hard capsule with a light blue cap and a body containing pale yellow powder~4. Storage conditions: Store in an airtight light proof container at room temperature."
RECRUITING
Uijeongbu Eulji Medical Center, Eulji University, Uijeongbu-si
NOT_YET_RECRUITING
Federal State Budgetary Institution, Moscow
RECRUITING
Federal State Budgetary Institution, Saint Petersburg
RECRUITING
Federal State Budgetary Institution, Saint Petersburg
RECRUITING
Federal State Budgetary Institution of Science, Kirov
NOT_YET_RECRUITING
Territorial State Budgetary Institution, Barnaul
RECRUITING
Hematology Centre based on City Clin. Hosp. n.a. S.P. Botkin, Moscow
RECRUITING
Ankara University Medical Faculty, Ankara
RECRUITING
Gazi University Medical Faculty, Ankara
RECRUITING
Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty, Istanbul
RECRUITING
Ege University Medical Faculty, Izmir
RECRUITING
Mersin University Medical Faculty, Mersin
RECRUITING
Ondokuz Mayis Univ. Med. Fac., Samsun
RECRUITING
CI Cherkasy Regional Oncological Dispensary of CRC, Cherkassy
RECRUITING
CTPI Chernihiv Regional Oncological Dispensary, Chernihiv
RECRUITING
CI Dnipropetrovsk CMCH #4 OF Dnipropetrovsk RC, Dnipro
RECRUITING
Institute of CR of SI NSC of Radiation Medicine of NAMSU H&T Unit, Kyiv
RECRUITING
SI Institute of Blood Pathology and Transfusion Medicine of AMSU, Lviv
Il-Yang Pharm. Co., Ltd.
INDUSTRY